Ls Investment Advisors, LLC Spectrum Pharmaceuticals Inc Transaction History

Ls Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.99 - $4.9 $10,390 - $17,027	-3,475 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$3.5 - $10.35 $12,071 - $35,697	-3,449 Reduced 49.81%	3,475 $13,000
Q1 2019 Apr 25, 2019	BUY	$9.08 - $11.84 $4,213 - $5,493	464 Added 7.18%	6,924 $74,000
Q4 2018 Feb 01, 2019	BUY	$6.39 - $16.99 $20,697 - $55,030	3,239 Added 100.56%	6,460 $57,000
Q3 2018 Nov 13, 2018	BUY	$16.52 - $24.82 $3,204 - $4,815	194 Added 6.41%	3,221 $54,000
Q1 2018 May 08, 2018	BUY	$16.09 - $23.07 $2,413 - $3,460	150 Added 5.21%	3,027 $49,000
Q4 2017 Feb 07, 2018	SELL	$13.36 - $20.73 $4,542 - $7,048	-340 Reduced 10.57%	2,877 $55,000
Q3 2017 Oct 19, 2017	BUY	$8.75 - $14.07 $28,148 - $45,263	3,217	3,217 $45,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.